V019-3813 Screening compound: N-({[1-(3,4-dimethoxyphenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-[(furan-2-yl)methyl]-2-methylpropanamide

V019-3813 Screening compound: N-({[1-(3,4-dimethoxyphenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-[(furan-2-yl)methyl]-2-methylpropanamide
V019-3813 Screening compound: N-({[1-(3,4-dimethoxyphenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-[(furan-2-yl)methyl]-2-methylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-3813
N-({[1-(3,4-dimethoxyphenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-[(furan-2-yl)methyl]-2-methylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-3813

Molecular Formula

C29H32N4O6 (C29 H32 N4 O6)

Compound Name

N-({[1-(3,4-dimethoxyphenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-[(furan-2-yl)methyl]-2-methylpropanamide

IUPAC name

N-({[1-(34-dimethoxyphenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-[(furan-2-yl)methyl]-2-methylpropanamide

SMILES

CC(C)C(N(CC(Nc1nc(-c(cc2)ccc2OC)cn1-c(cc1)cc(OC)c1OC)=O)Cc1ccco1)=O

InChI

InChI=1S/C29H32N4O6/c1-19(2)28(35)32(16-23-7-6-14-39-23)18-27(34)31-29-30-24(20-8-11-22(36-3)12-9-20)17-33(29)21-10-13-25(37-4)26(15-21)38-5/h6-15,17,19H,16,18H2,1-5H3,(H,30,31,34)

InChI Key

HNCYFNZPOSIGLY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19827541

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

532.6

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.701

Distribution Coefficient, logD

4.701

Water Solubility, LogSw

-4.38

Polar Surface Area

83.218

Acid Dissociation Constant (pKa)

13.17

Base Dissociation Constant (pKb)

2.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.60

V019-3813 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V019-3813 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-3813?
Check Price and Availability of V019-3813, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-3813 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-3813
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-3813
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-3813 available by request